Literature DB >> 27960597

Ivermectin: a complimentary weapon against the spread of malaria?

Haoues Alout1, Brian D Foy1.   

Abstract

INTRODUCTION: Ivermectin has transformed the treatment of parasitic diseases and led to incommensurable benefits to humans and animals. Ivermectin is effective in treating several neglected infectious diseases and recently it has been shown to reduce malaria parasite transmission. Areas covered: Malaria control strategies could benefit from the addition of ivermectin to interrupt the transmission cycle if it is a long lasting formulation or repeatedly administered. In turn, this will help also to control neglected infectious diseases where the elimination goal has been slower to achieve. Despite the relevance of using ivermectin for integrated and sustained disease control, there are still essential questions that remain to be addressed about safety and practicality. The efficacy in various malaria ecologies and the interaction between control tools, either drugs or insecticides, are also important to assess. Expert commentary: Overlapping distribution of several infectious diseases reveals the benefit of integrating control programs against several infectious diseases into one strategy for cost effectiveness and to reach the elimination goals. The use of ivermectin to control malaria transmission will necessitate development and testing of long-lasting formulations or repeated treatments, and implementation of these treatments with other disease control tools may increase the chance of successful and sustained control.

Entities:  

Keywords:  Ivermectin; integrated control strategy; lymphatic filariasis; malaria; mass drug administration; neglected infectious diseases; trials; vector control

Mesh:

Substances:

Year:  2016        PMID: 27960597      PMCID: PMC5538249          DOI: 10.1080/14787210.2017.1271713

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  68 in total

1.  Drug-resistant Drosophila indicate glutamate-gated chloride channels are targets for the antiparasitics nodulisporic acid and ivermectin.

Authors:  N S Kane; B Hirschberg; S Qian; D Hunt; B Thomas; R Brochu; S W Ludmerer; Y Zheng; M Smith; J P Arena; C J Cohen; D Schmatz; J Warmke; D F Cully
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Evidence for p-glycoprotein modification of insecticide toxicity in mosquitoes of the Culex pipiens complex.

Authors:  D S Buss; A R McCaffery; A Callaghan
Journal:  Med Vet Entomol       Date:  2002-06       Impact factor: 2.739

Review 3.  Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame.

Authors:  Maria P Rebollo; Moses J Bockarie
Journal:  Expert Rev Anti Infect Ther       Date:  2013-07       Impact factor: 5.091

Review 4.  Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection.

Authors:  A P Plaisier; W A Stolk; G J van Oortmarssen; J D Habbema
Journal:  Parasitol Today       Date:  2000-07

5.  Interaction of the neurotoxic pesticides ivermectin and lindane with the enteric GABAA receptor-ionophore complex in the guinea-pig.

Authors:  T Coccini; S M Candura; L Manzo; L G Costa; M Tonini
Journal:  Eur J Pharmacol       Date:  1993-06-01       Impact factor: 4.432

Review 6.  Epidemiology of plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control.

Authors:  Simon Brooker; Willis Akhwale; Rachel Pullan; Benson Estambale; Siân E Clarke; Robert W Snow; Peter J Hotez
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

7.  Toxicity of bloodmeals from ivermectin-treated cattle to Anopheles gambiae s.l.

Authors:  M L Fritz; P Y Siegert; E D Walker; M N Bayoh; J R Vulule; J R Miller
Journal:  Ann Trop Med Parasitol       Date:  2009-09

8.  Selection at a P-glycoprotein gene in ivermectin- and moxidectin-selected strains of Haemonchus contortus.

Authors:  W J Blackhall; H Y Liu; M Xu; R K Prichard; R N Beech
Journal:  Mol Biochem Parasitol       Date:  1998-09-15       Impact factor: 1.759

9.  Plasmodium falciparum produce lower infection intensities in local versus foreign Anopheles gambiae populations.

Authors:  Caroline Harris; Isabelle Morlais; Thomas S Churcher; Parfait Awono-Ambene; Louis Clement Gouagna; Roch K Dabire; Didier Fontenille; Anna Cohuet
Journal:  PLoS One       Date:  2012-01-26       Impact factor: 3.240

10.  The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015.

Authors:  S Bhatt; D J Weiss; E Cameron; D Bisanzio; B Mappin; U Dalrymple; K Battle; C L Moyes; A Henry; P A Eckhoff; E A Wenger; O Briët; M A Penny; T A Smith; A Bennett; J Yukich; T P Eisele; J T Griffin; C A Fergus; M Lynch; F Lindgren; J M Cohen; C L J Murray; D L Smith; S I Hay; R E Cibulskis; P W Gething
Journal:  Nature       Date:  2015-09-16       Impact factor: 49.962

View more
  9 in total

1.  Insights into the impact of Ivermectin on some protein aspects linked to Culex pipiens digestion and immunity.

Authors:  Magda Said A Abdeltawab; S A Rifaie; E Y Shoeib; H A Abd El-Latif; M Badawi; W H Salama; A A Abd El-Aal
Journal:  Parasitol Res       Date:  2019-11-30       Impact factor: 2.289

2.  Repurposing isoxazoline veterinary drugs for control of vector-borne human diseases.

Authors:  Marie Miglianico; Maarten Eldering; Hannah Slater; Neil Ferguson; Pauline Ambrose; Rosemary S Lees; Karin M J Koolen; Katerina Pruzinova; Magdalena Jancarova; Petr Volf; Constantianus J M Koenraadt; Hans-Peter Duerr; Graham Trevitt; Baiyuan Yang; Arnab K Chatterjee; John Wisler; Angelika Sturm; Teun Bousema; Robert W Sauerwein; Peter G Schultz; Matthew S Tremblay; Koen J Dechering
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-02       Impact factor: 11.205

Review 3.  Broadening the range of use cases for ivermectin - a review of the evidence.

Authors:  Christian Kositz; John Bradley; Harry Hutchins; Anna Last; Umberto D'Alessandro; Michael Marks
Journal:  Trans R Soc Trop Med Hyg       Date:  2022-03-02       Impact factor: 2.455

4.  Ivermectin susceptibility and sporontocidal effect in Greater Mekong Subregion Anopheles.

Authors:  Kevin C Kobylinski; Ratawan Ubalee; Alongkot Ponlawat; Chanyapat Nitatsukprasert; Siriporn Phasomkulsolsil; Thanaporn Wattanakul; Joel Tarning; Kesara Na-Bangchang; Patrick W McCardle; Silas A Davidson; Jason H Richardson
Journal:  Malar J       Date:  2017-07-07       Impact factor: 2.979

Review 5.  Drugs in Development for Malaria.

Authors:  Elizabeth A Ashley; Aung Pyae Phyo
Journal:  Drugs       Date:  2018-06       Impact factor: 9.546

6.  Opinions of key stakeholders on alternative interventions for malaria control and elimination in Tanzania.

Authors:  Marceline F Finda; Nicola Christofides; Javier Lezaun; Brian Tarimo; Prosper Chaki; Ann H Kelly; Ntuli Kapologwe; Paul Kazyoba; Basiliana Emidi; Fredros O Okumu
Journal:  Malar J       Date:  2020-04-23       Impact factor: 2.979

7.  From informed consent to adherence: factors influencing involvement in mass drug administration with ivermectin for malaria elimination in The Gambia.

Authors:  Alexandra Fehr; Claudia Nieto-Sanchez; Joan Muela; Fatou Jaiteh; Omar Ceesay; Ebrima Maneh; Dullo Baldeh; Jane Achan; Edgard Dabira; Bakary Conteh; Joske Bunders-Aelen; Tom Smekens; Henk Broekhuizen; Umberto D'Alessandro; Koen Peeters Grietens
Journal:  Malar J       Date:  2021-04-26       Impact factor: 2.979

8.  Optimising systemic insecticide use to improve malaria control.

Authors:  Hannah R Meredith; Luis Furuya-Kanamori; Laith Yakob
Journal:  BMJ Glob Health       Date:  2019-11-11

9.  Effects of ivermectin treatment of backyard chickens on mosquito dynamics and West Nile virus transmission.

Authors:  Karen M Holcomb; Chilinh Nguyen; Brian D Foy; Michelle Ahn; Kurt Cramer; Emma T Lonstrup; Asli Mete; Lisa A Tell; Christopher M Barker
Journal:  PLoS Negl Trop Dis       Date:  2022-03-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.